Recon: FDA panel unanimously backs oral OTC contraceptive; FDA rejects ImmunityBio’s application for bladder cancer therapy
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy